Chrysalis Biotherapeutics is developing TP508 to combat effects of radiation.
Credit
copyright 2009
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.